A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.

Get the full Xeris Pharmaceuticals, Inc. company profile
Access contacts, investors, buying signals & more
A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.
Portfolio company of VentureWell

Modu Tech
Modu Tech offers general contractors and individual owners alike with turnkey carpentry products by providing a one stop shop for framing labor, building materials and trusses. Since 1986, Modu Tech has specialized in multi-family apartments operating with our-in house partner Stark Truss Baltimore. We offer a complete and vertically integrated manufacturing and installation process. Our close relationship with the National Framers Council offers constant updates to changing market trends and other new industry-based information that keeps Modu Tech connected with other framers throughout the country while also providing an opportunity for us to share our knowledge back to the community through Webinars and regular meetings.
$4.4M Pre-seed
today

DIMENSION
A first-of-its-kind fund partnering with founders at the interface of technology and life sciences to transform the trajectory of life on earth
$1.6M Seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Aligned Marketplace | Series a | $20.0M | today |
| 2 | ![]() Vals AI United States | Series a | $40.0M | today |
| 3 |
| $7.2B |
| 1y ago |
| 3 | ![]() Illumina United States | Unknown | $7.1B | 1y ago |
| 4 | ![]() GRAIL United States | Unknown | $7.1B | 1y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 7mo ago |
![]() Tagup United States |
| Series a |
| $14.8M |
| today |
| 4 | ![]() Centricity United States | Series a | $33.6M | 1d ago |
| 5 | ![]() COSMOS LAB(코스모스랩) | Series a | $15.6M | 1d ago |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Xeris Pharmaceuticals, Inc. and reach their contacts directly.
Start free trialCarissa H.
Senior Director, Marketing Strategy
Mike M.
Regional Business Director, Rare Disease (Endocrinology)
Unlock 8 more key decision-makers at Xeris Pharmaceuticals, Inc. with verified emails and LinkedIn.
Start free trial
TuDOC
Recently received

Shyld AI
Recently received

Cardia, Inc.
Recently received